Evidence map›Paper›PMID 34472678›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Dichloro Butenediamides as Irreversible Site-Selective Protein Conjugation Reagent.

Victor Laserna, Daniel Abegg, Cláudia F Afonso, Esther M Martin, Alexander Adibekian, Peter Ravn, Francisco Corzana, Gonçalo J L Bernardes

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Advances in Proximity-Assisted Bioconjugation.Accounts of chemical research · 2025
    Review
  5. Article
  6. Fast Cysteine Bioconjugation Chemistry.Chemistry (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  7. OrganometallicBioconjugate chemistry · 2022
    Article
  8. Article
  9. Dichloro Butenediamides as Irreversible Site-Selective Protein Conjugation Reagent.Angewandte Chemie (International ed. in English) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 6 countries.

Victor LasernaYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW, Cambridge, UK.
Daniel AbeggDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Fl, 33458, USA.
Cláudia F AfonsoInstituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina Universidade de Lisboa, Avenida Professor Egas Moniz, 1649-028, Lisboa, Portugal.ORCID 0000-0003-4228-8834
Esther M MartinAstraZeneca, R&D BioPharmaceuticals Unit|Antibody Discovery & Protein Engineering (ADPE), Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
Alexander AdibekianDepartment of Chemistry, The Scripps Research Institute, 130 Scripps Way, Jupiter, Fl, 33458, USA.
Peter RavnAstraZeneca, R&D BioPharmaceuticals Unit|Antibody Discovery & Protein Engineering (ADPE), Milstein Building, Granta Park, Cambridge, CB21 6GH, UK.
Francisco CorzanaDepartamento de Química, Centro de Investigación en Síntesis Química, Universidad de La Rioja, 26006, Logroño, Spain.
Gonçalo J L BernardesYusuf Hamied Department of Chemistry, University of Cambridge, Lensfield Road, CB2 1EW, Cambridge, UK.ORCID 0000-0001-6594-8917
AstraZeneca (United Kingdom) · GBScripps Research Institute · USUniversity of Lisbon · PTUniversidad de La Rioja · ESUniversity of Cambridge · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe maleic-acid derivatives as robust cysteine-selective reagents for protein labelling with comparable kinetics and superior stability relative to maleimides. Diamide and amido-ester derivatives proved to be efficient protein-labelling species with a common mechanism in which a spontaneous cyclization occurs upon addition to cysteine. Introduction of chlorine atoms in their structures triggers ring hydrolysis or further conjugation with adjacent residues, which results in conjugates that are completely resistant to retro-Michael reactions in the presence of biological thiols and human plasma. By controlling the microenvironment of the reactive site, we can control selectivity towards the hydrolytic pathway, forming homogeneous conjugates. The method is applicable to several scaffolds and enables conjugation of different payloads. The synthetic accessibility of these reagents and the mild conditions required for fast and complete conjugation together with the superior stability of the conjugates make this strategy an important alternative to maleimides in bioconjugation.

Indexed as

DiamideHumansModels, MolecularMolecular StructureProteinsDiamideProteinsbioconjugationcysteineirreversibilitymaleimidesMichael addition

Identifiers

PMID34472678
PMCPMC8596790
OpenAlexW3198510309

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.